Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-26-074599
Filing Date
2026-06-16
Accepted
2026-06-16 16:30:44
Documents
15
Effectiveness Date
2026-06-16

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2617870d1_s8.htm S-8 47263
2 EXHIBIT 5.1 tm2617870d1_ex5-1.htm EX-5.1 11834
3 EXHIBIT 23.1 tm2617870d1_ex23-1.htm EX-23.1 2101
4 EXHIBIT 99.1 tm2617870d1_ex99-1.htm EX-99.1 142979
5 EX-FILING FEES tm2617870d1_ex-filingfees.htm   iXBRL EX-FILING FEES 16642
6 GRAPHIC tm2617870d1_ex5-1img001.jpg GRAPHIC 10290
  Complete submission text file 0001104659-26-074599.txt   356762

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2617870d1_ex-filingfees_htm.xml XML 5356
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-296824 | Film No.: 261095067
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)